1DZG
N135Q-S380C-ANTITHROMBIN-III
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SRS BEAMLINE PX9.6 |
Synchrotron site | SRS |
Beamline | PX9.6 |
Temperature [K] | 100 |
Detector technology | CCD |
Detector | MARRESEARCH |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 68.610, 99.540, 88.690 |
Unit cell angles | 90.00, 104.79, 90.00 |
Refinement procedure
Resolution | 20.000 - 2.800 |
R-factor | 0.228 * |
Rwork | 0.228 |
R-free | 0.29700 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2ant |
RMSD bond length | 0.011 * |
RMSD bond angle | 0.021 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | AMoRE |
Refinement software | REFMAC |
Data quality characteristics
Overall | |
Low resolution limit [Å] | 20.000 |
High resolution limit [Å] | 2.800 |
Rmerge | 0.131 |
Total number of observations | 98714 * |
Number of reflections | 27983 * |
<I/σ(I)> | 7.4 |
Completeness [%] | 98.3 |
Redundancy | 3.5 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | Batch method * | 6.5 | 5MG/ML 1:1 MIX OF INHIBITORY: LATENT ANTITHROMBIN-III, 10.5% PEG 4000, 65 MM NACACODYLATE, PH 6.5 |
Crystallization Reagents in Literatures
ID | crystal ID | solution | reagent name | concentration (unit) | details |
1 | 1 | 1 | protein | 5 (mg/ml) | |
2 | 1 | 1 | PEG4000 | 10.5 (%) | |
3 | 1 | 1 | sodium cacodylate | 65 (mM) |